90 related articles for article (PubMed ID: 31787738)
1. Human Heavy Chain Antibody Genes Elicited in Thai Dengue Patients during DENV2 Secondary Infection.
Thammasonthijarern N; Puangmanee W; Sriburin P; Injampa S; Chatchen S; Phumirattanaprapin W; Pipattanaboon C; Ramasoota P; Pitaksajjakul P
Jpn J Infect Dis; 2020 Mar; 73(2):140-147. PubMed ID: 31787738
[TBL] [Abstract][Full Text] [Related]
2. Lower IgG somatic hypermutation rates during acute dengue virus infection is compatible with a germinal center-independent B cell response.
Godoy-Lozano EE; Téllez-Sosa J; Sánchez-González G; Sámano-Sánchez H; Aguilar-Salgado A; Salinas-Rodríguez A; Cortina-Ceballos B; Vivanco-Cid H; Hernández-Flores K; Pfaff JM; Kahle KM; Doranz BJ; Gómez-Barreto RE; Valdovinos-Torres H; López-Martínez I; Rodriguez MH; Martínez-Barnetche J
Genome Med; 2016 Feb; 8(1):23. PubMed ID: 26917418
[TBL] [Abstract][Full Text] [Related]
3. Complexity of Neutralizing Antibodies against Multiple Dengue Virus Serotypes after Heterotypic Immunization and Secondary Infection Revealed by In-Depth Analysis of Cross-Reactive Antibodies.
Tsai WY; Durbin A; Tsai JJ; Hsieh SC; Whitehead S; Wang WK
J Virol; 2015 Jul; 89(14):7348-62. PubMed ID: 25972550
[TBL] [Abstract][Full Text] [Related]
4. B Cell Responses during Secondary Dengue Virus Infection Are Dominated by Highly Cross-Reactive, Memory-Derived Plasmablasts.
Priyamvada L; Cho A; Onlamoon N; Zheng NY; Huang M; Kovalenkov Y; Chokephaibulkit K; Angkasekwinai N; Pattanapanyasat K; Ahmed R; Wilson PC; Wrammert J
J Virol; 2016 Jun; 90(12):5574-85. PubMed ID: 27030262
[TBL] [Abstract][Full Text] [Related]
5. Dengue virus neutralization and antibody-dependent enhancement activities of human monoclonal antibodies derived from dengue patients at acute phase of secondary infection.
Sasaki T; Setthapramote C; Kurosu T; Nishimura M; Asai A; Omokoko MD; Pipattanaboon C; Pitaksajjakul P; Limkittikul K; Subchareon A; Chaichana P; Okabayashi T; Hirai I; Leaungwutiwong P; Misaki R; Fujiyama K; Ono K; Okuno Y; Ramasoota P; Ikuta K
Antiviral Res; 2013 Jun; 98(3):423-31. PubMed ID: 23545366
[TBL] [Abstract][Full Text] [Related]
6. Antibody avidity following secondary dengue virus type 2 infection across a range of disease severity.
Lau L; Green AM; Balmaseda A; Harris E
J Clin Virol; 2015 Aug; 69():63-7. PubMed ID: 26209381
[TBL] [Abstract][Full Text] [Related]
7. Dissecting the human serum antibody response to secondary dengue virus infections.
Patel B; Longo P; Miley MJ; Montoya M; Harris E; de Silva AM
PLoS Negl Trop Dis; 2017 May; 11(5):e0005554. PubMed ID: 28505154
[TBL] [Abstract][Full Text] [Related]
8. Mapping the Human Memory B Cell and Serum Neutralizing Antibody Responses to Dengue Virus Serotype 4 Infection and Vaccination.
Nivarthi UK; Kose N; Sapparapu G; Widman D; Gallichotte E; Pfaff JM; Doranz BJ; Weiskopf D; Sette A; Durbin AP; Whitehead SS; Baric R; Crowe JE; de Silva AM
J Virol; 2017 Mar; 91(5):. PubMed ID: 28031369
[TBL] [Abstract][Full Text] [Related]
9. A new quaternary structure epitope on dengue virus serotype 2 is the target of durable type-specific neutralizing antibodies.
Gallichotte EN; Widman DG; Yount BL; Wahala WM; Durbin A; Whitehead S; Sariol CA; Crowe JE; de Silva AM; Baric RS
mBio; 2015 Oct; 6(5):e01461-15. PubMed ID: 26463165
[TBL] [Abstract][Full Text] [Related]
10. The expression profile of human peripheral blood mononuclear cell miRNA is altered by antibody-dependent enhancement of infection with dengue virus serotype 3.
Jiang L; Sun Q
Virol J; 2018 Mar; 15(1):50. PubMed ID: 29566761
[TBL] [Abstract][Full Text] [Related]
11. Longitudinal analysis of acute and convalescent B cell responses in a human primary dengue serotype 2 infection model.
Nivarthi UK; Tu HA; Delacruz MJ; Swanstrom J; Patel B; Durbin AP; Whitehead SS; Pierce KK; Kirkpatrick BD; Baric RS; Nguyen N; Emerling DE; de Silva AM; Diehl SA
EBioMedicine; 2019 Mar; 41():465-478. PubMed ID: 30857944
[TBL] [Abstract][Full Text] [Related]
12. Infection of Aedes albopictus Mosquito C6/36 Cells with the
Teramoto T; Huang X; Armbruster PA; Padmanabhan R
J Virol; 2019 Aug; 93(15):. PubMed ID: 31092581
[TBL] [Abstract][Full Text] [Related]
13. Natural antibody responses to the capsid protein in sera of Dengue infected patients from Sri Lanka.
Nadugala MN; Jeewandara C; Malavige GN; Premaratne PH; Goonasekara CL
PLoS One; 2017; 12(6):e0178009. PubMed ID: 28582388
[TBL] [Abstract][Full Text] [Related]
14. Dengue virus infection-enhancement activity in neutralizing antibodies of healthy adults before dengue season as determined by using FcγR-expressing cells.
Ly MHP; Moi ML; Vu TBH; Tun MMN; Saunders T; Nguyen CN; Nguyen AKT; Nguyen HM; Dao TH; Pham DQ; Nguyen TTT; Le TQM; Hasebe F; Morita K
BMC Infect Dis; 2018 Jan; 18(1):31. PubMed ID: 29321001
[TBL] [Abstract][Full Text] [Related]
15. Use of a Recombinant Gamma-2 Herpesvirus Vaccine Vector against Dengue Virus in Rhesus Monkeys.
Bischof GF; Magnani DM; Ricciardi M; Shin YC; Domingues A; Bailey VK; Gonzalez-Nieto L; Rakasz EG; Watkins DI; Desrosiers RC
J Virol; 2017 Aug; 91(16):. PubMed ID: 28592531
[TBL] [Abstract][Full Text] [Related]
16. Demonstration of marmosets (Callithrix jacchus) as a non-human primate model for secondary dengue virus infection: high levels of viraemia and serotype cross-reactive antibody responses consistent with secondary infection of humans.
Moi ML; Takasaki T; Omatsu T; Nakamura S; Katakai Y; Ami Y; Suzaki Y; Saijo M; Akari H; Kurane I
J Gen Virol; 2014 Mar; 95(Pt 3):591-600. PubMed ID: 24323638
[TBL] [Abstract][Full Text] [Related]
17. Replacement of pr gene with Japanese encephalitis virus pr using reverse genetics reduces antibody-dependent enhancement of dengue virus 2 infection.
Wang Y; Si L; Luo Y; Guo X; Zhou J; Fang D; Yan H; Zeng G; Jiang L
Appl Microbiol Biotechnol; 2015 Nov; 99(22):9685-98. PubMed ID: 26219500
[TBL] [Abstract][Full Text] [Related]
18. Impact of Dengue Virus Serotype 2 Strain Diversity on Serological Immune Responses to Dengue.
Keasey SL; Smith JL; Fernandez S; Durbin AP; Zhao BM; Ulrich RG
ACS Infect Dis; 2018 Dec; 4(12):1705-1717. PubMed ID: 30347144
[TBL] [Abstract][Full Text] [Related]
19. Detection of dengue virus serotypes 1, 2 and 3 in selected regions of Kenya: 2011-2014.
Konongoi L; Ofula V; Nyunja A; Owaka S; Koka H; Makio A; Koskei E; Eyase F; Langat D; Schoepp RJ; Rossi CA; Njeru I; Coldren R; Sang R
Virol J; 2016 Nov; 13(1):182. PubMed ID: 27814732
[TBL] [Abstract][Full Text] [Related]
20. Modulation of Dengue/Zika Virus Pathogenicity by Antibody-Dependent Enhancement and Strategies to Protect Against Enhancement in Zika Virus Infection.
Khandia R; Munjal A; Dhama K; Karthik K; Tiwari R; Malik YS; Singh RK; Chaicumpa W
Front Immunol; 2018; 9():597. PubMed ID: 29740424
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
